RxDoctor Payments Data

Oluwakemi Osidele

Psychiatric/Mental Health · Frederick, MDNPI 1649649468

Payments from drug & device makers

$2,930in general payments, 2019–2025

Across 171 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$827
  • Gilead$428
  • Alkermes, Inc.$405
  • Indivior Inc.$361
  • Orexo US, Inc.$149
  • Otsuka America Pharmaceutical, Inc.$145
  • plus $614 from 10 others

What the payments were for

  • Food & beverage$2,89499%
  • Education$361%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,930 in reported general payments places this provider in the 90th percentile of 1,461 psychiatric/mental health providers in Maryland.

See all psychiatric/mental health providers in Maryland

Medicare billing

Part B allowed, 2024
$38,851
Medicare patients
70
Services billed
500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala13$51,193
Invega SustennaPaliperidone Palmitate13$45,328
SublocadeBuprenorphine17$35,478
Abilify MaintenaAripiprazole12$34,847
RexultiBrexpiprazole22$31,858
OzempicSemaglutide15$14,740
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl120$8,630
LinzessLinaclotide11$5,596
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine45$2,249
Methylphenidate Hcl15$709
Diclofenac Sodium20$556
Clonazepam64$516
Buspirone Hcl26$501
Trazodone Hcl28$454
Gabapentin59$439

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$145$66,70534 claims
GileadBiktarvy$428$51,19313 claims
Johnson & JohnsonInvega Sustenna$68$45,32813 claims
Indivior Inc.Sublocade$361$35,47817 claims
AbbVieLinzess$827$5,59611 claims
Almatica Pharma LLCSertraline Hcl$23$19150 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,461 psychiatric/mental health providers in Maryland.

Other psychiatric/mental health in Frederick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →